Highlights MorphoSys AG Deutsche Boerse AG

Equities

MOR2

US6177602025

Market Closed - Deutsche Boerse AG Other stock markets 02:04:04 2024-07-12 am EDT			5-day change	1st Jan Change
16.9 ^EUR	+3.05%		+3.05%	+101.19%

Jul. 12	Novartis Seeks Squeeze Out Approval at MorphoSys AGM	MT
Jun. 26	European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novartis Seeks Squeeze Out Approval at MorphoSys AGM	Jul. 12	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Jun. 26	MT
Dpa-AFX Overview: COMPANIES from 20/06/2024 - 15:15	Jun. 20	DP
Novartis: towards the filing of a buyout offer for MorphoSys	Jun. 20	CF
MorphoSys Set to Delist Following Acquisition by Novartis	Jun. 20	MT
MorphoSys Inks Delisting Agreement After Takeover by Novartis	Jun. 20	MT
Biotech company Morphosys will soon disappear from the stock exchange	Jun. 20	RE
MorphoSys to Leave Deutsche Börse’s MDAX, TecDAX Indices	Jun. 19	MT
Three newcomers to the MDax - Rational, TUI and Traton move up	Jun. 06	RE
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	Jun. 04	MT
Novartis data42 AG completed the acquisition of MorphoSys AG from group of shareholders.	May. 29	CI
European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading	May. 20	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading	May. 17	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	May. 16	MT
Dpa-AFX Overview: COMPANIES from 16.05.2024 - 15:15	May. 16	DP
Novartis: presents results of tender offer for MorphoSysy	May. 16	CF
Novartis Takeover Bid for MorphoSys Tops Minimum Acceptance Threshold	May. 16	MT
European Equities Traded in the US as American Depositary Receipts Decline	Apr. 30	MT
MorphoSys AG Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30	CI
Novartis target Morphosys multiplies losses - takeover schedule stands	Apr. 29	DP

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights MorphoSys AG Deutsche Boerse AG

Equities

MOR2

US6177602025

Highlights

Filters